1-12 of 12
Yukio Kondo, MD
Close
Sort by
Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Kazuyuki Shimada, MD, Motoko Yamaguchi, MD PhD, Yoshiko Atsuta, MD PhD, Kosei Matsue, MD PhD, Keijiro Sato, MD, Shigeru Kusumoto, MD PhD, Hirokazu Nagai, MD PhD, Jun Takizawa, MD PhD, Noriko Fukuhara, MD PhD, Koji Nagafuji, MD PhD, Kana Miyazaki, MD PhD, Eiichi Ohtsuka, MD, Masataka Okamoto, MD PhD, Yasumasa Sugita, MD PhD, Toshiki Uchida, MD PhD, Satoshi Kayukawa, MD, Atsushi Wake, MD PhD, Daisuke Ennishi, MD PhD, Yukio Kondo, MD, Tohru Izumi, MD, Yoshihiro Kin, MD, Kunihiro Tsukasaki, MD PhD, Daigo Hashimoto, Masaaki Yuge, MD PhD, Atsumi Yanagisawa, Yachiyo Kuwatsuka, MD PhD, Satoko Shimada, MD, Yasufumi Masaki, MD PhD, Nozomi Niitsu, MD PhD, Hitoshi Kiyoi, MD PhD, Ritsuro Suzuki, MD PhD, Takashi Tokunaga, MD PhD, Shigeo Nakamura, MD, Tomohiro Kinoshita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 350.
https://doi.org/10.1182/blood-2019-126798
Published: 2019
Journal Articles

Loss of HLA Class-I Expression In Leukemic Cells That Relapsed After HLA-Matched and -Mismatched SCT

Yukio Kondo, MD, PhD, Takamasa Katagiri, Bsc, Kohei Hosokawa, MD, Kinya Ohata, MD, Hirohito Yamazaki, MD, PhD, Seishi Ogawa, MD, PhD, Shinji Nakao, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2541.
https://doi.org/10.1182/blood.V116.21.2541.2541
Published: 2010
Journal Articles

GITR Ligation with GITR Ligand On Leukemic Cells Suppresses Induction of Leukemia-Associated Antigen Specific T Cells by Increasing Indoleamine 2, 3-Dioxygenase (IDO) Activity Leading to Kynurenine Secretion.

Yukio Kondo, MD, PhD, Luis Espinoza, MD, PhD, Takamasa Katagiri, PhD, Zhirong Qi, MD, Shinji Nakao, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3557.
https://doi.org/10.1182/blood.V114.22.3557.3557
Published: 2009
Journal Articles

GITR Ligand on Leukemic Myeloid Dendritic Cells Suppresses Induction of Leukemia-Associated Antigen-Specific CTLs from Naïve CD8 + T Cells.

Yukio Kondo, MD, PhD, Takamasa Katagiri, PhD, Kinya Ohata, MD, Shinji Nakao, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2347.
https://doi.org/10.1182/blood.V112.11.2347.2347
Published: 2008
Journal Articles

The FcγRllla Polymorphism Correlates with Chronic Graft-Versus-Host Disease and Treatment Related Mortality.

Akiyoshi Takami, MD, PhD, J. Luis Espinoza, MD, Ken Ishiyama, MD, PhD, Satomi Ohyachi, Yuki Kato, Yoshimi Kawamura, Yukio Kondo, MD, PhD, Shizuka Yasue, Shigeki Ohtake, MD, PhD, Shinji Nakao, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2237.
https://doi.org/10.1182/blood.V112.11.2237.2237
Published: 2008
Journal Articles

A Novel Strategy for the Treatment of Acute Graft-Versus-Host Disease Using the Adsorbent To Remove Excessive Inflammatory Cytokines.

Akiyoshi Takami, MD, PhD, Takanori Teshima, MD, PhD, Koshin Ushizaki, Takumi Taniguchi, MD, PhD, Tohru Endo, Hiroshi Sakurai, PhD, Yukio Kondo, MD, PhD, Hirohito Yamazaki, MD, PhD, Shigeru Shimadoi, MD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5001.
https://doi.org/10.1182/blood.V110.11.5001.5001
Published: 2007
Journal Articles

Circulating Leukemic Myeloid Dendritic Cells from Patient with Leukemia Elicit CDK2-Specific CTLs from Allogeneic HLA-A24 + Naive CD8 + T Cells.

Yukio Kondo, MD, Kinya Ohata, M.D., Shinji Nakao, M.D.
Journal: Blood
Blood (2007) 110 (11): 3228.
https://doi.org/10.1182/blood.V110.11.3228.3228
Published: 2007
Journal Articles

Monocyte Colony-Stimulating Factor Enhances Rituximab-Dependent Cellular Cytotoxicity by Monocytes.

Akiyoshi Takami, MD, PhD, FJSIM, Shigeru Shimadoi, MD, Yukio Kondo, MD, PhD, Hirokazu Okumura, MD, PhD, Shinji Nakao, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2533.
https://doi.org/10.1182/blood.V108.11.2533.2533
Published: 2006
Journal Articles

CDK2-Specific CTLs Can Be Generated In Vivo from Donor Derived T Cells in HLA-A24 + Patients with Leukemia in Remission after Allogeneic Stem Cell Transplantation.

Yukio Kondo, MD, Xingmin Feng, Ph.D., Yoshihisa Kumano, M.D., Shinji Nakao, M.D.
Journal: Blood
Blood (2006) 108 (11): 3173.
https://doi.org/10.1182/blood.V108.11.3173.3173
Published: 2006
Journal Articles

Aberrantly Expressed Neutrophil Elastase (ELA2) Cleaves Cyclin E (CCNE) in the Nucleus and Cytoplasm of Acute Lymphocytic Leukemia Yielding Novel Leukemia-Associated Antigens.

Ken Ishiyama, MD, Yukio Kondo, MD, Eric D. Wieder, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD
Journal: Blood
Blood (2006) 108 (11): 4429.
https://doi.org/10.1182/blood.V108.11.4429.4429
Published: 2006
Journal Articles

Two Cyclin-Dependent Kinase Derived Peptides Are Potential Leukemia-Associated-Antigens Able To Eradicate Acute Myeloid Leukemia Cells after Allogeneic Stem Cell Transplantation.

Yukio Kondo, MD, Xingmin Feng, Xuzhang Lu, Kanako Mochizuki, MD, Jeffrey J. Molldrem, MD, Shinji Nakao, MD
Journal: Blood
Blood (2005) 106 (11): 3103.
https://doi.org/10.1182/blood.V106.11.3103.3103
Published: 2005
Journal Articles

High Avidity Cyclin E-Derived Peptide-Specific CTL Contribute to Induction of Remission after Stem Cell Transplantation without Associated Graft-Versus-Host Disease.

Ken Ishiyama, MD, Yukio Kondo, MD, Eric Wieder, PhD, Sijie Lu, PhD, Jeffrey Molldrem, MD
Journal: Blood
Blood (2005) 106 (11): 1424.
https://doi.org/10.1182/blood.V106.11.1424.1424
Published: 2005